iNOS gene transfer for graft disease

Trends in Cardiovascular Medicine

Volumn 14, Issue 7, 2004, Pages 267-272

  Barbato, Joel E ^a   Tzeng, Edith ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTITHROMBOCYTIC AGENT; ARGININE; BETA GALACTOSIDASE; CALCIUM CHANNEL BLOCKING AGENT; GENE PRODUCT; IMMUNOSUPPRESSIVE AGENT; NAKED DNA; NITRIC OXIDE SYNTHASE; PLASMID VECTOR; POLITEF; VIRUS VECTOR;

ARTERIOLOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; BYSTANDER EFFECT; CELL PROLIFERATION; CORONARY ARTERY OBSTRUCTION; DNA VECTOR; EX VIVO STUDY; GENE TARGETING; GENE TRANSFER; GRAFT FAILURE; HUMAN; INFLAMMATORY INFILTRATE; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 8144228103     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2004.07.005     Document Type: Review

References (34)

1. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy BMJ 308 1994 159 168
2. L Campeau, M Enjalbert, and J Lesperance Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery Circulation 68 1983 II1 II7
3. KS Cross, MN el Sanadiki, and JJ Murray Functional abnormalities of experimental autogenous vein graft neoendothelium Ann Surg 208 1988 631 638
4. GM FitzGibbon, AJ Leach, and WJ Keon Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation J Thorac Cardiovasc Surg 91 1986 773 778
5. V Fuster, P Charlton, and A Boyd Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients Hum Gene Ther 12 2001 2025 2027
6. UC Garg, and A Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J Clin Invest 83 1989 1774 1777
7. DA Geller, CJ Lowenstein, and RA Shapiro Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes Proc Natl Acad Sci USA 90 1993 3491 3495
8. SE Greenwald, and CL Berry Improving vascular grafts: the importance of mechanical and haemodynamic properties J Pathol 190 2000 292 299
9. P Huang, WJ Hawthorne, and A Peng Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model Am J Surg 181 2001 492 498
10. TS Huber, JW Carter, and RL Carter Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review J Vasc Surg 38 2003 1005 1011
11. T Ishii, K Okadome, and K Komori Natural course of endothelium-dependent and -independent responses in autogenous femoral veins grafted into the arterial circulation of the dog Circ Res 72 1993 1004 1010
12. MR Kibbe, S Nie, and T Yoneyama Optimization of ex vivo inducible nitric oxide synthase gene transfer to vein grafts Surgery 126 1999 323 329
13. MR Kibbe, J Li, and S Nie Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate J Vasc Surg 31 2000 1214 1228
14. MR Kibbe, E Tzeng, and SL Gleixner Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia J Vasc Surg 34 2001 156 165
15. K Komori, VB Schini, and P Gloviczki The impairment of endothelium-dependent relaxations in reversed vein grafts is associated with a reduced production of cyclic guanosine monophosphate J Vasc Surg 14 1991 67 75
16. MH Kown, A Yamaguchi, and CL Jahncke L-arginine polymers inhibit the development of vein graft neointimal hyperplasia J Thorac Cardiovasc Surg 121 2001 971 980
17. P Kubes, M Suzuki, and DN Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc Natl Acad Sci USA 88 1991 4651 4655
18. MJ Mann, AD Whittemore, and MC Donaldson Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498
19. RE Morris, W Cao, and X Huang Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells Transplant Proc 27 1995 430 431
20. A Muhs, B Heublein, and J Schletter Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation Hum Gene Ther 14 2003 375 383
21. MW Radomski, RM Palmer, and S Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 1987 1057 1058
22. SJ Schwab, JR Raymond, and M Saeed Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses Kidney Int 36 1989 707 711
23. LL Shears, MR Kibbe, and AD Murdock Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo J Am Coll Surg 187 1998 295 306
24. RL Stoltenberg, J Geraghty, and DM Steele Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine Transplantation 60 1995 993 998
25. JH Tordoir, JM Herman, and TS Kwan Long-term follow-up of the polytetrafluoroethylene (PTFE) prosthesis as an arteriovenous fistula for haemodialysis Eur J Vasc Surg 2 1988 3 7
26. E Tzeng, TR Billiar, and PD Robbins Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer Proc Natl Acad Sci USA 92 1995 11,771 11,775
27. E Tzeng, LL Shears, and PD Robbins Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia Mol Med 2 1996 211 225
28. E Tzeng, T Yoneyama, and K Hatakeyama Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I Surgery 120 1996 315 321
29. E Tzeng, YM Kim, and BR Pitt Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis Surgery 122 1997 255 263
30. HE Von der Leyen, GH Gibbons, and R Morishita Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene Proc Natl Acad Sci USA 92 1995 1137 1141
31. BH Walpoth, M Pavlicek, and B Celik Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts Eur J Cardiothorac Surg 19 2001 487 492
32. K Wang, PD Kessler, and Z Zhou Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model Mol Ther 7 2003 597 603
33. NE West, H Qian, and TJ Guzik Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production Circulation 104 2001 1526 1532
34. M Ziche, L Morbidelli, and E Masini Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P J Clin Invest 94 1994 2036 2044